7025-19-6, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 7025-19-6, molecular formula is C6H7NO3S2, introducing its new discovery.
A carbazole derivative, its preparation method and in anti-tumor applications (by machine translation)
The present invention provides a carbazole derivative, its preparation method and in anti-tumor applications, carbazole derivatives having formula I structure, R1 And R2 Independently selected from hydrogen, halogen, alkoxy, C1 – C4 alkyl, halogenated alkyl, nitro and nitrile in the one or more; R3 Selected from carboxyl, methyl, phenyl or cyano; X is CH2 Or carbonyl; m=0 – 3; n=0 – 3. The derivatives inhibit topoisomerase II activity; it is non-built-in type of Topo II catalytic inhibitors, can be used for preparing topoisomerase II as the target of the anti-tumor drug; it can inhibit the multi-tumor cell strain proliferation, can be used for the preparation of anticancer drugs. Carbazole derivatives in 2.5 – 20mumol/L under the topoisomerase II have a strong inhibiting effect; the sub-cervical cancer cells, lung cancer cells, human leukemia cells and human prostate cancer cell has strong inhibiting effect. (by machine translation)
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.7025-19-6, you can also check out more blogs about7025-19-6
Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H792N | ChemSpider